Unknown

Dataset Information

Shielding reduced incidence of COVID-19 in patients with inflammatory arthritis but vulnerability is associated with increased mortality.


ABSTRACT:

Objectives

Investigate whether individuals with inflammatory arthritis (IA), their treatments and shielding status affect the risk of adverse outcomes from COVID-19 for the entire population of Wales, UK.

Methods

Retrospective, population-based cohort study using linked, anonymized electronic health data from SAIL Databank, including primary/secondary care, rheumatology, Office for National Statistics Mortality and COVID-19 laboratory data. Individuals aged 18 years and over testing positive for COVID-19 between March 2020 and May 2021 with READ Codes present for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis formed the study cases.

Results

A total of 1966 people with IA and 166 602 without tested positive for COVID-19. The incidence rate was 3.5

SUBMITTER: Cooksey R 

PROVIDER: S-EPMC9248059 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature